National Cancer Institute
Industry
- Academic and Research Institutions
Latest on National Cancer Institute
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur
BridgeBio Pharma, Inc. announced a $200m venture financing on 2 May that will enable portfolio oncology firm TheRas to spin out as BridgeBio Oncology Therapeutics (BBOT), a private and independen
“It's of no use really for people to survive early childhood infectious diseases just to die prematurely of cancer,” observed a senior executive of the US National Cancer Institute (NCI) underscorin
The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o